U.S. Markets open in 4 hrs 31 mins

How This Small Biotech Could Take On Merck In Cervical Cancer Drugs

ALLISON GATLIN
How This Small Biotech Could Take On Merck In Cervical Cancer Drugs

Iovance Biotherapeutics stock popped in high volume Thursday after the Food and Drug Administration granted it accelerated development of its cervical cancer treatment known as LN-145.